Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of ST-246 in Healthy Volunteers
NCT00907803Phase 2Completed
- Sponsor
- SIGA Technologies
- Start
- Jun 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tecovirimat in orthopoxviral disease, sponsored by SIGA Technologies. Started Jun 2009; status: completed.
02
Drugs
tecovirimat
03
Conditions
orthopoxviral disease
Beyond the preview
Go deeper on NCT00907803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00907803.